|
30 Oct 2019 |
Unique Alzheimer's Disease Tau Vaccine Shows Great Potential in Pre-Clinical Studies
|
|
29 Oct 2019 |
Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine
|
|
29 Oct 2019 |
GSK candidate vaccine demonstrates sustained level of protection against active pulmonary tuberculosis
|
|
29 Oct 2019 |
RhoVac Receives Approval in Finland to Start Clinical Phase IIb Study in Prostate Cancer
|
|
23 Oct 2019 |
BlueWillow Receives FDA Clearance to Begin Phase 1 Study of its Intranasal Anthrax Vaccine
|
|
18 Oct 2019 |
Bavarian Nordic Updates on Phase 2 Study of CV301 in Bladder Cancer
|
|
18 Oct 2019 |
Merck Receives EU CHMP Positive Opinion for Investigational V920 Ebola Zaire Vaccine for Protection Against Ebola Virus Disease
|
|
17 Oct 2019 |
Stallergenes Greer and Anergis Initiate New Study to Predict Efficacy of Second-Generation Allergen Immunotherapy
|
|
15 Oct 2019 |
Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults
|
|
08 Oct 2019 |
Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
|
|
08 Oct 2019 |
Prokarium Secures £4.6M from Wellcome to Fund the Clinical Development of its Lead Vaccine Programme
|
|
08 Oct 2019 |
Advaxis Announces Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial
|
|
04 Oct 2019 |
Caliviri Demonstrates That RNA Processing Errors Are a Rich Source of Tumor Neoantigens for Cancer Vaccines
|
|
02 Oct 2019 |
Sabin Vaccine Institute Receives $20.5 Million From BARDA With Potential of up to $128 Million to Develop Ebola Sudan and Marburg Vaccines
|
|
01 Oct 2019 |
Themis Bioscience and ZIKAVAX Consortium Announce Initiation of Phase 1 Zika Vaccine Trial
|
|
30 Sep 2019 |
Preliminary Results From IMV’s Phase 2 Basket Trial Evaluating DPX-Survivac as a Combination Therapy in Patients With Advanced and Metastatic Solid Tumors to Be Presented at ESMO Congress 2019
|
|
27 Sep 2019 |
Vaxart’s Tableted Oral Bivalent Norovirus Vaccine Meets Primary and Secondary Endpoints in Phase 1b Study
|
|
27 Sep 2019 |
Treos Bio Reports Updated Positive Results from a Phase 1/2 Clinical Trial of Precision Cancer Vaccine Plus Maintenance Therapy in Patients with Metastatic Colorectal Cancer
|
|
27 Sep 2019 |
AbbVie Receives FDA Approval of MAVYRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks for Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis Across All Genotypes
|
|
27 Sep 2019 |
Meissa Vaccines Closes $30 Million Financing to Advance RSV Vaccine into Clinical Trials
|
|
27 Sep 2019 |
Curevo Vaccine Announces Interim Results of Phase I Clinical Trial of CRV-101
|
|
25 Sep 2019 |
Immunicum AB (publ) Announces Complete Topline Data Analysis from Phase II MERECA Trial
|
|
25 Sep 2019 |
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
|
|
22 Sep 2019 |
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction
|
|
19 Sep 2019 |
PDS Biotechnology Reports Clinical Data for Its Novel Immunotherapy PDS0101 in Follow up to Phase 1 Human Trial
|
